<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xue Y</submitter><funding>National Key Research and Development Program of China</funding><pagination>6947</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11241798</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(13)</volume><pubmed_abstract>&lt;i>Toxoplasma gondii&lt;/i>, an important opportunistic pathogen, underscores the necessity of developing novel therapeutic drugs and identifying new drug targets. Our findings indicate that the half-maximal inhibitory concentrations (IC&lt;sub>50&lt;/sub>) of KU60019 and CP466722 (abbreviated as KU and CP) against &lt;i>T. gondii&lt;/i> are 0.522 μM and 0.702 μM, respectively, with selection indices (SI) of 68 and 10. Treatment with KU and CP affects the in vitro growth of &lt;i>T. gondii&lt;/i>, inducing aberrant division in the daughter parasites. Transmission electron microscopy reveals that KU and CP prompt the anomalous division of &lt;i>T. gondii&lt;/i>, accompanied by cellular enlargement, nuclear shrinkage, and an increased dense granule density, suggesting potential damage to parasite vesicle transport. Su</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>The Effects and Mechanism of ATM Kinase Inhibitors in &lt;i>Toxoplasma gondii&lt;/i>.</pubmed_title><pmcid>PMC11241798</pmcid><funding_grant_id>2023YFD1802400</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Ying Z</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Pei Y</pubmed_authors><pubmed_authors>Yin M</pubmed_authors><pubmed_authors>Xue Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Effects and Mechanism of ATM Kinase Inhibitors in &lt;i>Toxoplasma gondii&lt;/i>.</name><description>&lt;i>Toxoplasma gondii&lt;/i>, an important opportunistic pathogen, underscores the necessity of developing novel therapeutic drugs and identifying new drug targets. Our findings indicate that the half-maximal inhibitory concentrations (IC&lt;sub>50&lt;/sub>) of KU60019 and CP466722 (abbreviated as KU and CP) against &lt;i>T. gondii&lt;/i> are 0.522 μM and 0.702 μM, respectively, with selection indices (SI) of 68 and 10. Treatment with KU and CP affects the in vitro growth of &lt;i>T. gondii&lt;/i>, inducing aberrant division in the daughter parasites. Transmission electron microscopy reveals that KU and CP prompt the anomalous division of &lt;i>T. gondii&lt;/i>, accompanied by cellular enlargement, nuclear shrinkage, and an increased dense granule density, suggesting potential damage to parasite vesicle transport. Su</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-04-20T03:23:21.58Z</modification><creation>2026-04-20T03:14:35.225Z</creation></dates><accession>S-EPMC11241798</accession><cross_references><pubmed>39000057</pubmed><doi>10.3390/ijms25136947</doi></cross_references></HashMap>